PPARG and chronic obstructive pulmonary disease: Of note, adiponectin levels were also shown to be increased upon treatment with the FDA-approved PPAR-γ agonist thiazolidinediones (77), and in our study we indeed find an increased PPAR-γ expression on PBMC from COPD patients.